- active not recruitingPHASE2
A Phase 2a/b Study of the Efficacy and Safety of Subcutaneous Amlitelimab in Adults With Nonresponsive Celiac Disease
This study is testing a new medicine, amlitelimab, for adults with coeliac disease that isn't getting better with a gluten-free diet. It looks at how well the medicine works and if it's safe, by checking changes in the gut and how people feel.
United States · Argentina · Australia - ongoing, recruitingHuman Pharmacology (Phase I)- Other
A Phase 1b Study to Characterize the Safety and Tolerability of TEV-53408 in Adults with Celiac Disease
This study is looking into a new medication called TEV-53408 for adults with coeliac disease. It's an early-stage trial focusing on making sure the medication is safe and can be handled well by the body, rather than how well it treats the condition.
Finland - ongoing, recruitingTherapeutic exploratory (Phase II)
KAN-101-03: A Phase 2a Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of KAN-101 In Participants With Celiac Disease
This study is testing a new medicine, KAN-101, for people with coeliac disease. It wants to see if the medicine can help the gut lining heal and reduce symptoms, and if it's safe to use. Patients will receive either the medicine or a dummy treatment.
Finland · Ireland · Poland